StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 03/22/2013 -- StockRunway.com issues special report on the Top-Gaining Healthcare Stocks - Rockwell Medical (NASDAQ:RMTI), InterMune (NASDAQ:ITMN), AstraZeneca (NYSE:AZN)
Rockwell Medical Inc (NASDAQ:RMTI) traded higher after it was the subject of a positive Seeking Alpha post. The report suggested that RMTI is expected to move higher on positive Phase III results due in July.
Rockwell Medical Inc (RMTI) moved up +7.36% and closed at $3.50 in the last trading session with the total traded volume of 1.45 million shares. That’s more than the average volume of 350,286. RMTI is now trading below its 50 day moving average of -37.49% and 200 day moving average of -53.06%.
It has outstanding shares of 21.30 million with the total market cap of $74.55million and its beta value stands at 0.81 times which shows that stock is less volatile.
What was the Moving Force behind RMTI On Bullish Run? Read This Research Report on RMTI
InterMune Inc (NASDAQ:ITMN) recently received a positive tone from British regulators on the prospects for marketing the company’s centerpiece drug Esbriet, providing support to further build momentum for the drug’s eventual acceptance. The U.K.’s National Institute for Health and Clinical Excellence issued its final review and recommended Esbriet for treatment of the lung disease known as idiopathic pulmonary fibrosis, or IPF.
For How Long ITMN will Fight for Profitability? Read This Trend Analysis report
InterMuneInc(NASDAQ:ITMN) added +4.00% with the closing price of $9.36. The overall volume in the last trading session was 2.62 million shares. Its fifty two week range was $7.21-$15.52. The total market capitalization remained $617.91million.
ITMN is ahead its 52 week low with 29.82% and its last month price volatility remained 4.23%. Its beta coefficient was 2.26 with a target price of $14.57. In its share capital, the company has 81.60million outstanding shares while 80.95million shares have been floated in market. It has insider ownership of 0.09% with its institutional ownership remained 89.11%. EPS this year advanced 31.90%.
AstraZeneca plc (ADR) (NYSE:AZN) trended higher after disclosing a restructuring of its SG&A activities that could lead to a global reduction in headcount of approximately 2,300. The greater part of this headcount impact is related to programs under way or already communicated to affected staff. The combining of this SG&A restructuring has been announced after two previously announced programs.
AstraZeneca plc (ADR)(NYSE:AZN) increased +3.83% to close at $47.95 in the last trading session and its total traded volume was 5.38 million shares, beating the average volume of 1.86 million. The company has market cap of $59.79 billion.
For How Long AZN Gloss will Attract Investors? Find out via this report
It has earnings per share of $4.98, net profit margin of 22.62% and operating margin of 29.13%. The stock has positive year-to-date performance of 5.66% and is trading above its 50 day moving average of +3.89% and 200 day moving average of +7.44%.
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you&aposre new to penny stocks or a seasoned veteran, you&aposll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway&aposs service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
For more information on this press release visit: http://www.sbwire.com/press-releases/top-gaining-healthcare-stocks-rockwell-medical-nasdaqrmti-intermune-nasdaqitmn-astrazeneca-nyseazn-227262.htm